ABTA Funded Research Develops New Brain Tumor Treatments

Ben Ripstein is the president of Midwest Motors, Inc., in Lake Zurich, Illinois. In that capacity, he oversees the company’s daily activities and sales and is responsible for buying cars to show on the sales floor. A committed member of his community, Ben Ripstein supports several charitable organizations, including local organizations like Laremont School and national organizations like the American Brain Tumor Association.

The American Brain Tumor Association (ABTA) has advanced the treatment and understanding of brain tumors since its founding in 1973. As the first national organization committed to brain tumors, the ABTA funds brain tumor research, interacts with patients and their families, and works with other organizations and groups to reach its goals.

Recently, ABTA research funding helped with the development of new brain tumor drugs. These new drugs target malignant tumors such as glioblastoma multiforme (GBM), a common and aggressive type of tumor, and other malignant gliomas. ABTA funded the research as a part of its Discovery Grant program, which launched to support future research for new drug testing and new therapies. Although the drugs are still years away from human testing, researchers are optimistic about the future potential of the two drugs.


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s